Rare History, Common Disease

Rare History, Common Disease A unique population in Quebec is helping reveal the genetics behind common diseases such as heart disease and asthma. But as it loses its isolation, is time running out? By David Secko Related Articles 1 The novel loci include regions that contain novel candidate Crohn disease genes such as JAKMIP1, which is involved in interleukin-23 signaling, and LOC285484, which is similar to a secreted cytokine potentially involved in

Written byDavid Secko
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

A unique population in Quebec is helping reveal the genetics behind common diseases such as heart disease and asthma. But as it loses its isolation, is time running out?

By David Secko

1 The novel loci include regions that contain novel candidate Crohn disease genes such as JAKMIP1, which is involved in interleukin-23 signaling, and LOC285484, which is similar to a secreted cytokine potentially involved in intestinal inflammation.

Raelson says the Quebec population is ideal for genetic research. Here, 2,600 individuals migrated from France between 1608 and 1760, then experienced a genetic bottleneck, creating a population with less "genetic noise" or variation. This homogeneity makes it easier to spot disease-causing mutations (see Figure). "Founder populations can help in identifying smaller [genetic] effects with more power," says Ariel Darvasi of the Hebrew University of Jerusalem, who works with the Ashkenazi Jewish population.

Raelson says that the genetic bottleneck - in which ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies